Ahmed A, Iaconisi G, Di Molfetta D, Coppola V, Caponio A, Singh A
Int J Mol Sci. 2025; 26(1.
PMID: 39795950
PMC: 11719790.
DOI: 10.3390/ijms26010092.
Nesci S, Rubattu S
Biomedicines. 2024; 12(6).
PMID: 38927514
PMC: 11201685.
DOI: 10.3390/biomedicines12061307.
Li N, Deng J, Zhang J, Yu F, Ye F, Hao L
Inflammation. 2024; 47(5):1634-1647.
PMID: 38429403
PMC: 11549132.
DOI: 10.1007/s10753-024-01998-4.
Caggiano E, Taniguchi C
Cancer Metastasis Rev. 2024; 43(2):777-794.
PMID: 38194152
PMC: 11156755.
DOI: 10.1007/s10555-023-10157-4.
Deng Y, Huang X, Chen X, Wang M, Tian L, Zhou H
Nutrients. 2023; 15(22).
PMID: 38004214
PMC: 10674164.
DOI: 10.3390/nu15224820.
Metabolic Responses of Normal Rat Kidneys to a High Salt Intake.
Shimada S, Hoffmann B, Yang C, Kurth T, Greene A, Liang M
Function (Oxf). 2023; 4(5):zqad031.
PMID: 37575482
PMC: 10413938.
DOI: 10.1093/function/zqad031.
Mitochondria in endothelial cells angiogenesis and function: current understanding and future perspectives.
Luo Z, Yao J, Wang Z, Xu J
J Transl Med. 2023; 21(1):441.
PMID: 37407961
PMC: 10324193.
DOI: 10.1186/s12967-023-04286-1.
Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer Therapy.
Zhang L, Wei Y, Yuan S, Sun L
Int J Mol Sci. 2023; 24(5).
PMID: 36902385
PMC: 10003438.
DOI: 10.3390/ijms24054954.
Association between Polymorphism of Genes , , , and and Susceptibility to Non-Small Cell Lung Cancer in the Brazilian Amazon.
Pereira E, Modesto A, Fernandes B, Burbano R, Assumpcao P, Fernandes M
Genes (Basel). 2023; 14(2).
PMID: 36833388
PMC: 9957054.
DOI: 10.3390/genes14020461.
Long-term 1,2-dimethylhydrazine triggers pathological remodeling of colon mucosa through repression of sestrin2, nuclear factor (erythroid-derived 2)-like 2, and sirtuin4 stimulating mitochondrial stress and metabolic reprogramming.
Allal B, Bounaama A, Silva D, Quintas C, Dahlouk S, Goncalves J
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(6):1291-1307.
PMID: 36723607
DOI: 10.1007/s00210-023-02403-x.
Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review.
Lauria G, Curcio R, Lunetti P, Tiziani S, Coppola V, Dolce V
Cancers (Basel). 2023; 15(2).
PMID: 36672360
PMC: 9857038.
DOI: 10.3390/cancers15020411.
Construction and validation of a novel algorithm based on oncosis-related lncRNAs comprising the immune landscape and prediction of colorectal cancer prognosis.
Xiang H, Shen X, Chen E, Chen W, Song Z
Oncol Lett. 2023; 25(2):63.
PMID: 36644148
PMC: 9827452.
DOI: 10.3892/ol.2022.13650.
UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control.
Luby A, Alves-Guerra M
Int J Mol Sci. 2022; 23(23).
PMID: 36499405
PMC: 9735768.
DOI: 10.3390/ijms232315077.
Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
Sun Y, Liu B, Xiao B, Jiang X, Xiang J, Xie J
Cancer Med. 2022; 12(5):5994-6008.
PMID: 36366731
PMC: 10028123.
DOI: 10.1002/cam4.5412.
Epstein-Barr Virus-Encoded MicroRNA-BART18-3p Promotes Colorectal Cancer Progression by Targeting De Novo Lipogenesis.
Meng Q, Sun H, Wu S, Familiari G, Relucenti M, Aschner M
Adv Sci (Weinh). 2022; 9(35):e2202116.
PMID: 36307872
PMC: 9762317.
DOI: 10.1002/advs.202202116.
UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling.
Sancerni T, Renoult O, Luby A, Caradeuc C, Lenoir V, Croyal M
Front Immunol. 2022; 13:960226.
PMID: 36275699
PMC: 9582289.
DOI: 10.3389/fimmu.2022.960226.
Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Knisbacher B, Lin Z, Hahn C, Nadeu F, Duran-Ferrer M, Stevenson K
Nat Genet. 2022; 54(11):1664-1674.
PMID: 35927489
PMC: 10084830.
DOI: 10.1038/s41588-022-01140-w.
LAMC1-mediated preadipocytes differentiation promoted peritoneum pre-metastatic niche formation and gastric cancer metastasis.
Fang Y, Dou R, Huang S, Han L, Fu H, Yang C
Int J Biol Sci. 2022; 18(7):3082-3101.
PMID: 35541892
PMC: 9066104.
DOI: 10.7150/ijbs.70524.
IL25 Enhanced Colitis-Associated Tumorigenesis in Mice by Upregulating Transcription Factor GLI1.
Liu J, Qian B, Zhou L, Shen G, Tan Y, Liu S
Front Immunol. 2022; 13:837262.
PMID: 35359953
PMC: 8963976.
DOI: 10.3389/fimmu.2022.837262.
UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients.
Huang J, Wang G, Liao K, Xie N, Deng K
J Ovarian Res. 2022; 15(1):16.
PMID: 35090503
PMC: 8800348.
DOI: 10.1186/s13048-022-00951-z.